Cervical nodal metastases from head and neck squamous cell carcinoma: MRI criteria for treatment assessment

Head and Neck

Volumn 38, Issue , 2016, Pages E1598-E1604

  King, Ann D ^a   Yu, Kwok Hung ^a   Mo, Frankie Kwok Fai ^a   Law, Benjamin King Hong ^a   Yuen, Tom Wing Cheung ^a   Bhatia, Kunwar S ^a   Vlantis, Alexander C ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

cancer; head and neck; metastatic nodes; MRI; treatment response

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CERVICAL LYMPH NODE METASTASIS; CHEMORADIOTHERAPY; DIFFUSION WEIGHTED IMAGING; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT OUTCOME; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84959110709     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24285     Document Type: Article

References (36)

1. Hamoir M, Ferlito A, Schmitz S, et al., The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol 2012; 48: 203-210.
2. Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A., Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck 2010; 32: 253-261.
3. Hermann RM, Christiansen H, Rödel RM., Lymph node positive head and neck carcinoma after curative radiochemotherapy: a long lasting debate on elective post-therapeutic neck dissections comes to a conclusion. Cancer Radiother 2013; 17: 323-331.
4. Stenson KM, Haraf DJ, Pelzer H, et al., The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000; 126: 950-956.
5. Lango MN, Myers JN, Garden AS., Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol 2009; 19: 24-28.
6. Goguen LA, Chapuy CI, Sher DJ, et al., Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngol Head Neck Surg 2010; 143: 367-374.
7. Clavel S, Charron MP, Bélair M, et al., The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012; 82: 567-573.
8. Kim SY, Kim JS, Yi JS, et al., Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Ann Surg Oncol 2011; 18: 2579-2584.
9. Yao M, Graham MM, Smith RB, et al., Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 2004; 60: 1410-1418.
10. Ong SC, Schöder H, Lee NY, et al., Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49: 532-540.
11. Farrag TY, Lin FR, Cummings CW, et al., Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope 2006; 116: 1864-1866.
12. Langerman A, Plein C, Vokes EE, et al., Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135: 1133-1136.
13. Moeller BJ, Rana V, Cannon BA, et al., Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 2009; 27: 2509-2515.
14. Liauw SL, Mancuso AA, Amdur RJ, et al., Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 2006; 24: 1421-1427.
15. Porceddu SV, Jarmolowski E, Hicks RJ, et al., Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005; 27: 175-181.
16. Porceddu SV, Pryor DI, Burmeister E, et al., Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011; 33: 1675-1682.
17. Tan A, Adelstein DJ, Rybicki LA, et al., Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2007; 133: 435-440.
18. Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R., PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 2006; 28: 487-495.
19. Thariat J, Ang KK, Allen PK, et al., Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: e367-e374.
20. Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT., A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 994-999.
21. Corry J, Peters L, Fisher R, et al., N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 2008; 30: 737-742.
22. Goguen LA, Posner MR, Tishler RB, et al., Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006; 132: 526-531.
23. Velázquez RA, McGuff HS, Sycamore D, Miller FR., The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004; 130: 74-77.
24. 18F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol 2009; 129: 893-899.
25. Nishimura G, Matsuda H, Taguchi T, et al., Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma. Anticancer Res 2012; 32: 595-600.
26. Isles MG, McConkey C, Mehanna HM., A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemotherapy. Clin Otolaryngol 2008; 33: 210-222.
27. Roy S, Tibesar RJ, Daly K, et al., Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy. Head Neck 2002; 24: 474-481.
28. Ojiri H, Mendenhall WM, Stringer SP, Johnson PL, Mancuso AA., Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 420-428.
29. Yeung AR, Liauw SL, Amdur RJ, et al., Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer 2008; 112: 1076-1082.
30. Labadie RF, Yarbrough WG, Weissler MC, Pillsbury HC, Mukherji SK., Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. AJNR Am J Neuroradiol 2000; 21: 310-314.
31. Sanguineti G, Corvo R, Benasso M, et al., Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999; 21: 223-228.
32. King AD, Tse GM, Ahuja AT, et al., Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology 2004; 230: 720-726.
33. Sumi M, Kimura Y, Sumi T, Nakamura T., Diagnostic performance of MRI relative to CT for metastatic nodes of head and neck squamous cell carcinomas. J Magn Reson Imaging 2007; 26: 1626-1633.
34. O'Sullivan B, Huang SH, Perez-Ordonez, et al., Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 2012; 103: 49-56.
35. Huang SH, O'Sullivan B, Xu W, et al., Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys 2013; 87: 1078-1085.
36. Sanguineti G, Ricchetti F, Wu B, et al., Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy. Head Neck 2012; 34: 1640-1647.